Ibrahim, H.
O’Sullivan, R.
Casey, D.
Murphy, J.
MacSharry, J.
Plant, B. J.
Murphy, D. M.
Article History
Received: 16 September 2019
Accepted: 27 November 2019
First Online: 20 December 2019
Ethics approval and consent to participate
: Approval was granted to carry out the above study at Cork University Hospitals, approval was granted by the Clinical Research Ethics Committee of the Cork Teaching Hospitals. {CREC Review Reference Number: ECM 4 (e) 25/07/2019}.Participants received information pertaining to this study prior to enrollment in the study, the rationale for undertaking the piece of research, study design, participant requirements, potential risks and side effects were explained. All Participants in this study gave their consent prior to being enrolled.
: Not applicable.
: HI, ROS, DC, JM, JMS, BJP report no conflicts of interest. DMM has received both speakers’ fees and fees for advisory boards from Astra Zeneca, GSK, Teva and Novartis. He has travelled to ERS 2018 as a guest of Astra Zeneca.